tm logo
Trademark Search
TIVDAQ

View On IC.GC.CA

TIVDAQ
REGISTERED

on 31 Dec 1969

Last Applicant/ Owned by

Seagen Inc.

21823 30th Drive S.E.Bothell WA 98021

US

Serial Number

2149847 filed on 25th Oct 2021

Registration Number

TMA1237022 registered on 07th Jun 2024

Registration expiry Date

25th Oct 2031

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

TIVDAQ

Trademark usage description

pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of nervous system diseases, for the Read More

Classification Information

Class [005]
Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of nervous system diseases, for the regulation of the immune system and for treatment of auto-immune diseases, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of cancer, and inflammatory disorders, for use in dermatology namely dermatitis, skin pigmentation diseases, acne, eczema, psoriasis, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology namely dermatitis, skin pigmentation diseases, acne, eczema, psoriasis, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology

Classification kind code

11

Class [042]
Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation

Classification kind code

11

Mark Details

Serial Number

2149847

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 16th Mar 2023		Agent Changed
Submitted for opposition 22
on 10th Mar 2023		Search Recorded
Submitted for opposition 20
on 10th Mar 2023		Examiner's First Report
Submitted for opposition 223
on 10th Mar 2023		Total Provisional Refusal
Submitted for opposition 256
on 26th Sep 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 25th Nov 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 24th Nov 2021		Formalized
Submitted for opposition 1
on 24th Nov 2021		Created
Submitted for opposition 30
on 25th Oct 2021		Filed
Submitted for opposition 228
on 25th Oct 2021		International Registration